Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Mucositis × Diphenhydramine × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 2 Vomiting 1 Stomatitis 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasm Metastasis 1 Nausea 1 Mucositis 1 Mesothelioma 1 Mastocytosis, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Leukemia 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Burkitt Lymphoma 1

Interventions

Radiotherapy 2 Radiation 2 Cisplatin 2 pegfilgrastim 1 hydrated silica gel-based toothpaste 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 Surgical Procedures, Operative 1 Selenomethionine 1 Lidocaine 1 Ketamine 1 Granulocyte Colony-Stimulating Factor 1 Fluorouracil 1 Filgrastim 1 Docetaxel 1 Diphenhydramine 1 Curcumin 1 Amifostine 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02606994 2019-02-06

TPvsM

Oral Defense, LLC

Phase 2 Terminated

Neoplasms, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡